Free Trial

OpGen (OPGN) Competitors

OpGen logo
$0.04 +0.00 (+0.77%)
As of 07/25/2025

OPGN vs. XGN, DCGO, EUDA, SERA, QIPT, CORBF, NAKA, KDLY, ATPC, and BNR

Should you be buying OpGen stock or one of its competitors? The main competitors of OpGen include Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), and Burning Rock Biotech (BNR). These companies are all part of the "healthcare" industry.

OpGen vs. Its Competitors

Exagen (NASDAQ:XGN) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

75.3% of Exagen shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 12.6% of Exagen shares are owned by company insiders. Comparatively, 43.8% of OpGen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Exagen had 8 more articles in the media than OpGen. MarketBeat recorded 8 mentions for Exagen and 0 mentions for OpGen. Exagen's average media sentiment score of 0.58 beat OpGen's score of 0.00 indicating that Exagen is being referred to more favorably in the media.

Company Overall Sentiment
Exagen Positive
OpGen Neutral

Exagen has a net margin of -27.34% compared to OpGen's net margin of -1,140.36%. OpGen's return on equity of 0.00% beat Exagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Exagen-27.34% -133.69% -34.87%
OpGen -1,140.36%N/A -287.58%

Exagen has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.66, suggesting that its stock price is 266% less volatile than the S&P 500.

Exagen has higher revenue and earnings than OpGen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exagen$56.72M2.73-$15.11M-$0.84-8.65
OpGen$2.67M0.15-$32.67MN/AN/A

Exagen presently has a consensus price target of $9.00, suggesting a potential upside of 23.80%. Given Exagen's stronger consensus rating and higher probable upside, equities research analysts clearly believe Exagen is more favorable than OpGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exagen
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
OpGen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Exagen beats OpGen on 12 of the 14 factors compared between the two stocks.

Get OpGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPGN vs. The Competition

MetricOpGenMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$396K$812K$5.70B$9.50B
Dividend YieldN/AN/A4.58%4.01%
P/E RatioN/AN/A28.4120.08
Price / Sales0.150.99432.3189.32
Price / CashN/AN/A36.2258.56
Price / Book0.000.118.675.88
Net Income-$32.67M-$27.68M$3.25B$258.89M
7 Day PerformanceN/AN/A4.25%3.71%
1 Month PerformanceN/AN/A10.51%11.72%
1 Year PerformanceN/AN/A35.68%18.01%

OpGen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPGN
OpGen
N/A$0.04
+0.8%
N/A-98.7%$396K$2.67M0.00100
XGN
Exagen
4.1808 of 5 stars
$6.97
-0.4%
$7.50
+7.6%
+258.1%$149.10M$55.64M-8.30220News Coverage
Upcoming Earnings
Analyst Forecast
DCGO
DocGo
2.059 of 5 stars
$1.42
-0.7%
$3.56
+150.7%
-58.9%$145.84M$616.55M-71.004,407News Coverage
Positive News
EUDA
EUDA Health
0.9069 of 5 stars
$3.09
-1.9%
N/A-17.8%$117.23M$4.01M0.002Upcoming Earnings
Gap Down
SERA
Sera Prognostics
0.7237 of 5 stars
$2.92
flat
N/A-59.5%$110M$80K-3.11120
QIPT
Quipt Home Medical
2.9902 of 5 stars
$2.02
-3.3%
$2.85
+41.1%
-40.7%$90.80M$245.91M-9.621,200
CORBF
Global Cord Blood
N/A$0.55
+0.1%
N/A-47.4%$66.91M$196.12M0.001,200Gap Up
NAKA
KindlyMD
N/A$10.95
-0.6%
N/AN/A$66.45M$2.72M-14.22N/A
KDLY
Kindly MD
N/A$11.02
-3.6%
N/A+453.3%$66.36M$2.47M-14.31N/A
ATPC
Agape ATP
0.8595 of 5 stars
$1.30
+0.8%
N/A-40.8%$64.51M$1.32M-2.1740Positive News
BNR
Burning Rock Biotech
1.6415 of 5 stars
$4.93
+4.8%
N/A+0.9%$50.58M$70.67M-2.611,390Positive News

Related Companies and Tools


This page (NASDAQ:OPGN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners